Health & Medicine
-
Listeria Outbreak in California Kills Infant, Sickens 10 Others
A listeriosis outbreak linked to ready-to-eat meat and poultry products has resulted in the death of an infant and at least ten…
-
Listeria outbreak in California kills infant, sickens 10
Health officials in California have confirmed that an outbreak of Listeria monocytogenes linked to ready‑to‑eat meat and poultry products has resulted in…
-
Listeria Outbreak Kills Infant in California
A recent listeria outbreak in California, United States, has resulted in the death of an infant and left at least ten other…
-
E. coli Outbreak Linked to Organic Carrots in the US
A deadly outbreak of E. coli linked to organic carrots grown in the United States has resulted in one death and dozens…
-
Organic Carrots Linked to E. Coli Outbreak, One Dead
/ HTML. Likely one headline then paragraphs. We need to ensure we do not add any extra info. Use only facts from…
-
E. coli Outbreak Hits 75 Cases in McDonald’s Quarter Pounders
The E. coli outbreak tied to McDonald’s Quarter Pounder hamburgers now stands at 75 confirmed cases as of October 25, 2024. That…
-
FDA Approves Genentech’s Inavolisib for PIK3CA-Mutated Advanced Breast Cancer
On 15 October 2024, the U.S. Food and Drug Administration granted market authorization to Inavolisib, a novel therapy from Genentech, a Roche…
-
Dana-Farber Retracts and Corrects Dozens of Papers, Then CEO Laurie Glimcher Steps Down
BOSTON, USA — Dana-Farber Cancer Institute is facing a leadership crisis and a wave of scientific corrections after an investigation uncovered research…
-
McDonald’s E. coli Outbreak Kills 1, Sickens 104
One person is dead. At least 104 others are sick. The cause: slivered onions on a Quarter Pounder. The outbreak linked to…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
Rwanda’s Marburg Outbreak in Kigali Kills 13, Infects 58
Just four weeks ago, Rwanda had no history of Marburg virus disease. Today, the nation is confronting its first outbreak, with 58…
-
Rwanda Reports First Marburg Virus Outbreak
The World Health Organization (WHO) has been informed of the first-ever outbreak of Marburg virus disease (MVD) in Rwanda, as reported on…
-
England’s Junior Doctors Accept 22% Pay Deal, Ending 18-Month NHS Dispute
United Kingdom, September 18, 2024 — cybernewschronicle.com — The 2022–2024 National Health Service (NHS) strikes were a series of concurrent industrial disputes…
-
FDA Approves First Non-Dopamine Schizophrenia Drug
September 17, 2024 — cybernewschronicle.com — For decades, the standard treatment for schizophrenia has revolved around one brain system: dopamine. Every major…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
FDA Approves Lazertinib With Amivantamab as First-Line Treatment for EGFR Lung Cancer
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
Gabon Confirms First Mpox Case in Man Who Returned From Uganda
Health authorities in Gabon announced on August 23 that a man who arrived by air from Uganda has tested positive for mpox.…
-
Gabon Reports First Mpox Case in Traveler from Uganda Recently
Health authorities in Gabon have confirmed the Central African nation’s first case of mpox, a viral disease, in a male patient who…
-
FDA Approves Voranigo, a Daily Pill That Delays Progression of Low-Grade Glioma
Each year, about 1,500 Americans receive a diagnosis of grade 2 glioma, a slowly progressing yet aggressive brain tumor. Until now, treatment…
-
FDA Approves Vorasidenib, First Systemic Therapy for IDH-Mutated Grade 2 Gliomas
On August 15, 2024, the U.S. Food and Drug Administration authorized the use of vorasidenib—marketed as Voranigo—for patients in the United States…
-
MAHA Push Is Changing How Americans Snack, NIQ Data Shows
WASHINGTON, D.C. — The slogan “Make America Healthy Again” is not new. Its roots stretch back decades through the public-health work of…
-
FDA Approves New Drug for Chronic Graft-Versus-Host Disease Treatment
/ HTML. Length 450-560 words. Must not add any extra content. Must not invent quotes. Must keep facts: August 2024, FDA approved…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























